This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

David M. Huchton, MD; John K. Niparko, MD
Baltimore, Md

Arch Otolaryngol Head Neck Surg. 1996;122(8):901.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Potentially Dangerous Drug Interactions With Terfenadine and Astemizole: An Update. Otolaryngologists should be continually mindful of the potentially devastating interactions of terfenadine and astemizole with other medications. A synopsis of the recent literature on this important issue should aid in recognizing and avoiding potentially dangerous therapeutic combinations.

Terfenadine (Seldane) has been associated with prolonging the cardiac QT_c interval when used alone, especially in high doses. Torsades de pointes, a potentially fatal cardiac tachyarrhythmia has also been associated with terfenadine when taken alone. Terfenadine is metabolized by the liver; it undergoes rapid first-pass metabolism and conversion to an active metabolite by way of the cytochrome P-450 enzyme system. Drugs that inhibit this enzymatic pathway, therefore, have been implicated in increasing terfenadine's serum level and thus its potential for toxic effects. The macrolide antibiotics erythromycin and trobandomycin have this action, and, in combination with terfenadine, have been implicated in cases of . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?